OD-OS GmbH – Trademark Portfolio

Entity Type: 16

OD-OS GmbH holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include MACUTHERM. The owner is based in 14513 Teltow.

Warthestrasse 21

14513 Teltow , DE

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OD-OS GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does OD-OS GmbH have?

OD-OS GmbH has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does OD-OS GmbH file in?

OD-OS GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are OD-OS GmbH's most well-known trademarks?

OD-OS GmbH's registered trademark portfolio includes well-known marks such as MACUTHERM. These are among 1 currently registered trademark in the portfolio.

What is OD-OS GmbH's trademark registration success rate?

OD-OS GmbH has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.